0897.HK

Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) announced on Wednesday its revenue fell 5.8% year-on-year to HK$347 million ($45 million) in the six months to September. But its profit of HK$23.7 million was up 577% over the same period.

The big profit gain, even as revenue fell, owed mainly to fair value gains related to the company’s investment properties. At the same time, its net impairment losses on properties, plants and equipment were smaller than the same period last year.

Wai Yuen Tong said its sales for the six-month period fell by 7.3% year-on-year due to changes in consumption patterns among local residents and tourists. To counter such negative effects, the company launched new products under the Wai Yuen Tong brand, expanded cross-border e-commerce channels, and cooperated with celebrities and key opinion leaders to increase its visibility.

Wai Yuen Tong’s shares fell 0.4% in Thursday trade in Hong Kong.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Illustration of Hong Kong as a ipo pipeline and crypto lab for China

Hong Kong: China’s IPO pipeline and crypto lab

Companies raised $13.6 billion through Hong Kong IPOs in the first half of the year, giving the city the global fundraising title for that period. What's behind the sudden boom? And a growing number of Chinese companies are experimenting with cryptocurrencies in Hong Kong, even as such currencies are banned on the Mainland. What's driving such different approaches on the Mainland and in Hong Kong?